Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
solo stove(US:DTC) Newsfile·2025-10-02 15:15 Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and OperationsOctober 02, 2025 3:15 AM EDT | Source: Defence Therapeutics Inc.Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce the appointment of Mark Lambermon, PhD, as Head of Quality and Operations. Dr. Lambermon brings over 20 ye ...